Theravance Biopharma Inc. (TBPH)
NASDAQ · Healthcare
Theravance Biopharma Inc. EPS 2012–2025
Theravance Biopharma Inc. annual/quarterly eps history and growth rate from 2019 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Theravance Biopharma Inc. eps for the quarter ending March 31, 2026 was $0.10, a 62.96% decrease year-over-year.
- Theravance Biopharma Inc. annual eps for 2025 was $2.06, a 279.13% decrease from 2024.
- Theravance Biopharma Inc. annual eps for 2024 was $1.15, a 15.00% increase from 2023.
- Theravance Biopharma Inc. annual eps for 2023 was $1.00, a 108.44% decrease from 2022.
- Theravance Biopharma Inc. annual eps for 2022 was $11.85.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Theravance Biopharma Inc. EPS — FAQ
Theravance Biopharma Inc. (TBPH) eps over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Theravance Biopharma Inc.'s eps?
Theravance Biopharma Inc. (TBPH) reported eps of $2.06 for fiscal 2025.
Where can I see TBPH's eps history?
The chart and table above show Theravance Biopharma Inc.'s eps by year and by quarter, including the growth rate.